Article
erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells.
American journal of respiratory cell and molecular biology - 1 Sept 1996
Grim J, Deshane J, Feng M, Lieber A, Kay M, Curiel D T
Abstract excerpt
erbB-2 is known to be overexpressed in several human malignancies including lung cancer. Because of its role in neoplastic transformation as well as its association with poor prognosis, this oncogene has been targeted through various anti-cancer methodologies. In this regard, we have recently demonstrated that erbB-2-overexpressing ovarian tumor cell lines transfected with an endoplasmic reticulum form of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
